122 related articles for article (PubMed ID: 32429648)
1. Nuclear CK19-immunopositive pseudoinclusions as a new additional objective diagnostic feature of papillary thyroid carcinoma.
Domagala P; Domagala W
Pol J Pathol; 2020; 71(1):1-6. PubMed ID: 32429648
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.
Cracolici V; Krausz T; Cipriani NA
Head Neck Pathol; 2018 Dec; 12(4):522-528. PubMed ID: 29512025
[TBL] [Abstract][Full Text] [Related]
3. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
Sadiq Q; Sekhri R; Dibaba DT; Zhao Q; Agarwal S
World J Surg Oncol; 2021 May; 19(1):143. PubMed ID: 33964951
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion.
Takagi S; Hirokawa M; Nagashima K; Higuchi M; Kadota K; Ishikawa R; Sato M; Miyauchi A; Miyake Y; Haba R
Endocr J; 2020 Dec; 67(12):1207-1214. PubMed ID: 32879160
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth.
Johnson DN; Furtado LV; Long BC; Zhen CJ; Wurst M; Mujacic I; Kadri S; Segal JP; Antic T; Cipriani NA
Arch Pathol Lab Med; 2018 Jul; 142(7):838-850. PubMed ID: 29582677
[TBL] [Abstract][Full Text] [Related]
6. Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
Koshikawa T; Fujita N; Ueda N; Ota Y; Sasaki E; Murakami Y; Hosoda W; Yatabe Y; Hanai N; Higuchi M; Hirokawa M; Miyauchi A
Endocr J; 2019 May; 66(5):475-483. PubMed ID: 30867345
[TBL] [Abstract][Full Text] [Related]
7. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
Bizzarro T; Martini M; Capodimonti S; Straccia P; Lombardi CP; Pontecorvi A; Larocca LM; Rossi ED
Cancer Cytopathol; 2016 Oct; 124(10):699-710. PubMed ID: 27717284
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.
Legesse T; Parker L; Heath J; Staats PN
J Am Soc Cytopathol; 2019; 8(1):11-17. PubMed ID: 30929754
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of CK19 and galectin-3 in differentiating papillary thyroid carcinoma from nonneoplastic lesions of thyroid.
Prasad PA; Raju K
J Cancer Res Ther; 2022; 18(3):644-649. PubMed ID: 35900535
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
Murtezaoglu AR; Gucer H
Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
[TBL] [Abstract][Full Text] [Related]
15. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
16. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions.
Palo S; Biligi DS
Malays J Pathol; 2017 Apr; 39(1):55-67. PubMed ID: 28413206
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.
Cho H; Kim JY; Oh YL
Pathol Int; 2018 Nov; 68(11):605-613. PubMed ID: 30350394
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group.
Rossi ED; Mehrotra S; Kilic AI; Toslak IE; Lim-Dunham J; Martini M; Fadda G; Lombardi CP; Larocca LM; Barkan GA
Cancer Cytopathol; 2018 Jan; 126(1):27-35. PubMed ID: 29024469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
